-
Something wrong with this record ?
Flexible regions govern promiscuous binding of IL-24 to receptors IL-20R1 and IL-22R1
J. Zahradník, L. Kolářová, Y. Peleg, P. Kolenko, S. Svidenská, T. Charnavets, T. Unger, JL. Sussman, B. Schneider,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
CZ.02.1.01/0.0/0.0/16_013/0001777
MEYS, Ministry of education, youth, and sports of the Czech Republic - International
CZ.1.05/1.1.00/02.0109
MEYS, Ministry of education, youth, and sports of the Czech Republic - International
LM2015043
MEYS, Ministry of education, youth, and sports of the Czech Republic - International
RVO 86652036
Akademie Věd České Republiky - International
16-20507S
Grantová Agentura České Republiky - International
NLK
Free Medical Journals
from 2005 to 1 year ago
Medline Complete (EBSCOhost)
from 2005-01-01 to 1 year ago
Wiley Free Content
from 2005 to 1 year ago
PubMed
31152679
DOI
10.1111/febs.14945
Knihovny.cz E-resources
- MeSH
- HeLa Cells MeSH
- Interleukins metabolism MeSH
- Crystallography, X-Ray MeSH
- Humans MeSH
- Receptors, Interleukin metabolism MeSH
- Signal Transduction MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Interleukin 24 (IL-24) is a cytokine with the potential to be an effective treatment for autoimmune diseases and cancer. However, its instability and difficulties in its production have hampered detailed biological and biophysical studies. We approached the challenges of IL-24 production by using the PROSS algorithm to design more stable variants of IL-24. We used homology models built from the sequences and known structures of IL-20 and IL-19 and predicted and produced several extensively mutated IL-24 variants that were highly stable and produced in large yields; one of them was crystallized (IL-24B, PDB ID 6GG1; 3D Interactive at http://proteopedia.org/w/Journal: FEBS_Journal:1). The mutated variants, however, lost most of their binding capacity to the extracellular parts of cognate receptors. While the affinity to the receptor 2 (IL-20R2) was preserved, the variants lost affinity to IL-20R1 and IL-22R1 (shared receptors 1). Back engineering of the variants revealed that reintroduction of a single IL-24 wild-type residue (T198) to the patch interacting with receptors 1 restored 80% of the binding affinity and signaling capacity, accompanied by an acceptable drop in the protein stability by 9 °C. Multiple sequence alignment explains the stabilizing effect of the mutated residues in the IL-24 variants by their presence in the related and more stable cytokines IL-20 and IL-19. Our homology-based approach can enhance existing methods for protein engineering and represents a viable alternative to study and produce difficult proteins for which only in silico structural information is available, estimated as >40% of all important drug targets.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025608
- 003
- CZ-PrNML
- 005
- 20201222154008.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/febs.14945 $2 doi
- 035 __
- $a (PubMed)31152679
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Zahradník, Jiří $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic. Weizmann Institute of Science, Rehovot, Israel.
- 245 10
- $a Flexible regions govern promiscuous binding of IL-24 to receptors IL-20R1 and IL-22R1 / $c J. Zahradník, L. Kolářová, Y. Peleg, P. Kolenko, S. Svidenská, T. Charnavets, T. Unger, JL. Sussman, B. Schneider,
- 520 9_
- $a Interleukin 24 (IL-24) is a cytokine with the potential to be an effective treatment for autoimmune diseases and cancer. However, its instability and difficulties in its production have hampered detailed biological and biophysical studies. We approached the challenges of IL-24 production by using the PROSS algorithm to design more stable variants of IL-24. We used homology models built from the sequences and known structures of IL-20 and IL-19 and predicted and produced several extensively mutated IL-24 variants that were highly stable and produced in large yields; one of them was crystallized (IL-24B, PDB ID 6GG1; 3D Interactive at http://proteopedia.org/w/Journal: FEBS_Journal:1). The mutated variants, however, lost most of their binding capacity to the extracellular parts of cognate receptors. While the affinity to the receptor 2 (IL-20R2) was preserved, the variants lost affinity to IL-20R1 and IL-22R1 (shared receptors 1). Back engineering of the variants revealed that reintroduction of a single IL-24 wild-type residue (T198) to the patch interacting with receptors 1 restored 80% of the binding affinity and signaling capacity, accompanied by an acceptable drop in the protein stability by 9 °C. Multiple sequence alignment explains the stabilizing effect of the mutated residues in the IL-24 variants by their presence in the related and more stable cytokines IL-20 and IL-19. Our homology-based approach can enhance existing methods for protein engineering and represents a viable alternative to study and produce difficult proteins for which only in silico structural information is available, estimated as >40% of all important drug targets.
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukiny $x metabolismus $7 D007378
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a receptory interleukinů $x metabolismus $7 D018123
- 650 _2
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kolářová, Lucie $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
- 700 1_
- $a Peleg, Yoav $u Weizmann Institute of Science, Rehovot, Israel.
- 700 1_
- $a Kolenko, Petr $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic. Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
- 700 1_
- $a Svidenská, Silvie $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
- 700 1_
- $a Charnavets, Tatsiana $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
- 700 1_
- $a Unger, Tamar $u Weizmann Institute of Science, Rehovot, Israel.
- 700 1_
- $a Sussman, Joel L $u Weizmann Institute of Science, Rehovot, Israel.
- 700 1_
- $a Schneider, Bohdan $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
- 773 0_
- $w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 286, č. 19 (2019), s. 3858-3873
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31152679 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222154004 $b ABA008
- 999 __
- $a ok $b bmc $g 1599753 $s 1116294
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 286 $c 19 $d 3858-3873 $e 20190612 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_013/0001777 $p MEYS, Ministry of education, youth, and sports of the Czech Republic $2 International
- GRA __
- $a CZ.1.05/1.1.00/02.0109 $p MEYS, Ministry of education, youth, and sports of the Czech Republic $2 International
- GRA __
- $a LM2015043 $p MEYS, Ministry of education, youth, and sports of the Czech Republic $2 International
- GRA __
- $a RVO 86652036 $p Akademie Věd České Republiky $2 International
- GRA __
- $a 16-20507S $p Grantová Agentura České Republiky $2 International
- LZP __
- $a Pubmed-20201125